분자유전학실험실 (단국대학교 분자생물학과)



 이성욱 ( 2018-02-01 23:59:10 , Hit : 466
 Severe Toxicity Reported in High-Dose AAV Gene Therapy in Animals

https://www.the-scientist.com/?articles.view/articleNo/51526/title/Severe-Toxicity-Reported-in-High-Dose-AAV-Gene-Therapy-in-Animals/&utm_campaign=TS_DAILY%20NEWSLETTER_2018&utm_source=hs_email&utm_medium=email&utm_content=60375850&_hsenc=p2ANqtz--UAWJsPDeDYrOcv2eGXij0pAM2ZqeXHlsHjnaNxFphh6BaagK9Gq46gjnyDPae5HESSi8FjAgfq0D4_rvPqstIAGh4yA&_hsmi=60375850/

The Scientist »
The Nutshell

Biotech stocks fell in response to the news.

By Jim Daley | January 31, 2018

Researchers reported severe, life-threatening toxicity in nonhuman primates and piglets treated with high-dose, adeno-associated virus (AAV9) gene therapy this Monday (January 29) in Human Gene Therapy. The news caused stocks of several leading biotech companies to tumble.

James Wilson, a molecular biologist at the University of Pennsylvania, and his colleagues found that an AAV9 variant (AAVhu68) used to deliver a human gene to spinal cord motor neurons in rhesus monkeys and piglets resulted in severe toxicity affecting the liver and motor neurons. Symptoms began appearing within five days of administering the gene therapy. One monkey and three piglets had to be euthanized.

“AAV still remains, from my experience over three decades, one of the safest delivery systems,” Wilson tells Xconomy. “We should expect with any biologic product that if you push the dose high enough, you’re going to encounter dose-limiting toxicities.”

Earlier this month, Wilson left his position on Solid Biosciences’s scientific advisory board, citing concerns about possible risks associated with of high doses of AAV vectors, which are used in the firm's muscular dystrophy gene therapy candidate, SGT-001. The Food and Drug Administration placed a partial clinical hold on SGT-001 last November, asking the company to make manufacturing adjustments and other changes before testing high doses of the drug.

In an accompanying editorial, Terence Flotte, the editor-in-chief of Human Gene Therapy, and Hildegard Büning, editor of Human Gene Therapy Methods, urge researchers to approach the study’s findings “in a balanced and responsible fashion.”

They note that the number of animals included in the study was small—only three per species—and that it was impossible to compare dose-response relationships with either liver or motor neuron toxicity because all animals were treated with the same dose. “[I]t is crucial that the members of our field neither ignore, nor overreact to these findings,” they write.

Stocks of three biotech companies—Avexis, Sarepta Therapeutics, and Solid Biosciences—fell when the study was announced.








1238   CRISPR Efficiency Tied to Cancer-Causing Process  이성욱 2018/06/13 154
1237   Gene Therapy Ever More Common for Rare Disorders  이성욱 2018/05/30 144
1236   RNA World May Have Started Spinning with Triplet-Based Synthesis  이성욱 2018/05/21 145
1235   CRISPR’s MAGESTIC Evolution Makes Gene Editing More Precise  이성욱 2018/05/08 224
1234   CRISPR-Cas9 Improved 10,000-Fold by Synthetic Nucleotides  이성욱 2018/04/17 236
1233   Nature Methods retracts CRISPR study  이성욱 2018/04/10 443
1232   릴리 '시람자' 간암 말기 임상시험 성공  이성욱 2018/04/07 270
1231   Powerful enzyme could make CRISPR gene-editing more versatile  이성욱 2018/03/01 280
  Severe Toxicity Reported in High-Dose AAV Gene Therapy in Animals  이성욱 2018/02/01 466
1229   Shields Up for New Cancer Gene-Therapy Virus  이성욱 2018/02/01 367
1228   JPM서 논란 ‘유전자가위 기술’ 올해의 마일스톤은?  이성욱 2018/01/21 455
1227   암 면역요법, 일부 환자에게만 효과 있는 이유  이성욱 2018/01/12 448
1226   [바이오토픽] CRISPR 기반 유전자치료를 방해하는 면역계  이성욱 2018/01/10 415
1225   [미국] 2017년, 유전자가위 기술을 통한 네 가지 사건들  이성욱 2018/01/10 362
1224   Using Oncolytic Viruses to Boost Response to Immune Checkpoint Inhibitors  이성욱 2018/01/05 364
1223   Alcohol Boosts Cancer Risk by Damaging Stem Cell DNA  이성욱 2018/01/05 339
1222   [바이오토픽] Science, 2017년 과학연구 총결산  이성욱 2017/12/27 368
1221   FDA Approves First Gene Therapy for Inherited Disease  이성욱 2017/12/22 341
1220   Spark Therapeutics shares rise on FDA approval of new gene therapy for blindness  이성욱 2017/12/20 245
1219   작년 바이오산업 규모 8조8775억원, 투자 13.9% 늘어  이성욱 2017/12/13 330

[1] 2 [3][4][5][6][7][8][9][10]..[63] [다음 10개]
 

Copyright 1999-2018 Zeroboard / skin by ROBIN